INTS Archived Articles
Intensity Therapeutics (NASDAQ:INTS): Pioneering Novel Immuno-Oncology Treatments to Transform Cancer Care
Published on March 13, 2025
Intensity Therapeutics (NASDAQ:INTS): Building a Formidable Pipeline to Tackle Solid Tumors
Published on November 30, 2024
INTS: Intensity Therapeutics Poised for Breakthrough in Cancer Treatment
Published on September 24, 2024